The Oncology Consortia of Criterium held their annual Investigator Meetings during the 2025 ASCO Annual Meeting. These gatherings foster an invaluable collaboration and innovation among key opinion leaders and prominent experts in the field, across a wide range of prestigious academic institutions and community sites – driving forward our shared mission to advance cancer research and improve patient outcomes.

We were privileged to have Dr. Wells Messersmith, Director of AGICC (Academic GI Cancer Consortium), and Dr. Thomas Flaig, Director of AURIC (Academic Urology Research Investigators Consortium), chair these meetings. Their leadership and expertise are instrumental in driving forward our consortia’s goals.

“Looking ahead, our consortia aim to expand our research initiatives, integrate cutting-edge technologies, and strengthen global partnerships to accelerate breakthroughs in oncology,” said Ronny Schnel, MA, Executive Director, Consortia Services at Criterium.